Codes / ICD10CM / M1A.2320

M1A.2320 Drug-induced chronic gout, left wrist, without tophus (tophi)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Drug-Induced Chronic Gout, Left Wrist, Without Tophus (tophi)

Summary

Drug-induced chronic gout, left wrist, without tophus is a form of arthritis affecting the left wrist joint, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms without the presence of tophi (urate crystal deposits) in this stage.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the left wrist joint and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

  • Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
  • Prolonged exposure to urate-raising drugs
  • Pre-existing hyperuricemia or gout history
  • Renal impairment affecting drug clearance

Symptoms

  • Recurrent episodes of intense left wrist pain, often with swelling and redness
  • Persistent warmth and tenderness in the affected wrist
  • Stiffness and limited range of motion in the left wrist
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests assess uric acid levels, while joint fluid analysis confirms urate crystal presence. Imaging (e.g., X-rays) evaluates joint damage, and the absence of tophi is noted clinically or radiographically.

Treatment Options

Treatment focuses on reducing uric acid levels and managing inflammation. Medications may include urate-lowering agents (e.g., allopurinol) and anti-inflammatories (e.g., NSAIDs or colchicine). Lifestyle modifications, such as dietary changes, may complement pharmacotherapy.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and joint damage may be minimized. Regular follow-up monitors uric acid levels and treatment efficacy. Untreated cases risk progressive joint damage and potential tophi formation.

Complications

Untreated or poorly managed cases may lead to chronic joint damage, reduced mobility, or the eventual development of tophi. Recurrent flares can impact quality of life and functional ability.

Lifestyle & Prevention

  • Avoid medications known to elevate uric acid (when possible)
  • Maintain a balanced diet low in purines
  • Stay hydrated to support uric acid excretion
  • Limit alcohol consumption, which can trigger flares

When to Seek Professional Help

Seek care for persistent wrist pain, swelling, or stiffness, especially if symptoms worsen or interfere with daily activities. Prompt evaluation is recommended for acute flare-ups or signs of infection.

Tips for Medical Coders

Document the left wrist involvement and the absence of tophi clearly. Ensure clinical notes specify the drug-induced etiology and confirm the absence of tophaceous deposits to support this code.

Book a walkthrough

M1A.2320 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.